Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant(TM) Touch Laser in Canada

Executive Summary

• Bausch Health’s Solta Medical announced the Canadian launch of the Clear + Brilliant® Touch laser system, approved by Health Canada on May 20 2025.
• The dual‑wavelength device is now available to Canadian physicians for non‑invasive skin rejuvenation across a broad range of indications.
• Launch expands Solta’s global footprint and adds a new revenue opportunity within Bausch Health’s aesthetics portfolio.

Key Details

• Regulatory approval: Health Canada cleared the Clear + Brilliant® Touch system on 20 May 2025.
• Device description: Dual‑wavelength fractional laser with two handpieces (1440 nm and 1927 nm) offering treatment for wrinkles, dyschromia, pigmentation, skin texture, pore size, and enhanced skin permeability.
• Market impact: Provides Canadian physicians with an advanced, customizable aesthetic solution; aligns with growing demand for non‑invasive skin rejuvenation in Canada.
• Corporate statements:
• Thomas J. Appio, CEO of Bausch Health, highlighted the launch as part of Solta’s global expansion and strong market interest in Canada.
• Jiny Kim, SVP of Solta Medical, emphasized the significance of bringing the system to Canadian providers and patients.
• Clinical background: Platform supported by more than 15 clinical studies demonstrating safety and efficacy for early‑sign signs of aging and overall skin improvement.
• Availability: Device now commercially available in Canada; further information and safety details at ca.clearandbrilliant.com/hcp.

Notable Quotes

“The Solta business continues to expand its global presence through its diverse and well‑established portfolio that supports the growing demand for high‑quality aesthetics solutions,” – Thomas J. Appio, CEO, Bausch Health.

“Expanding the availability of the Clear + Brilliant Touch System into Canada marks a significant step forward for Solta Medical… This launch reinforces Solta's leadership in supporting both providers and patients with technology that delivers safe, effective and customizable results,” – Jiny Kim, Senior Vice President, Solta Medical.